Second opinions and pathological review impact the clinical management of patients with muscle-invasive bladder cancer
This study highlights the importance of pathological re-evaluation of patients diagnosed with muscle-invasive bladder cancer. The significant discrepancy rate and its impact on the treatment decisions are noteworthy. Standardization of diagnostic practices is essential to mitigate variability among pathologists and facilities and to ensure optimal care for patients with muscle-invasive bladder cancer.
Authors
- Shuya Kandori (ORCID: https://orcid.org/0000-0003-4621-8470)
- Hiromitsu Negoro
- Takashi Kawahara (ORCID: https://orcid.org/0000-0002-7049-3379)
- Noriaki Sakamoto (ORCID: https://orcid.org/0000-0001-6573-6463)
- Daisuke Matsubara (ORCID: https://orcid.org/0000-0002-4115-7640)
- Yoshiyuki Nagumo (ORCID: https://orcid.org/0000-0003-0332-4791)
- Satoshi Nitta (ORCID: https://orcid.org/0000-0002-2855-1061)
- Masanobu Shiga (ORCID: https://orcid.org/0000-0003-1174-119X)
- Hiroyuki Nishiyama (ORCID: https://orcid.org/0009-0002-6589-5776)
Institutions
- University of Tsukuba (JP)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1007/s00345-025-05861-5
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00